RUA Life Sciences plc (FRA:AOHA)

Market Cap	10.39M +6.8%
Revenue (ttm)	4.92M +87.7%
Net Income	1.20K
EPS	0.00
Shares Out	n/a
PE Ratio	8,695.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1270
Previous Close	0.1270
Day's Range	0.1270 - 0.1390
52-Week Range	0.0815 - 0.1470
Beta	n/a
RSI	56.30
Earnings Date	Dec 11, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1996
• Employees: 40
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AOHA

Financial Performance

Financial numbers in GBP